October 29, 2019
Sumitomo Dainippon CEO & President Hiroshi Nomura With the LOE of its bread-and-butter antipsychotic Latuda (lurasidone) looming large, Sumitomo Dainippon Pharma is poised to funnel cash generated through its impending deal with Roivant Sciences into R&D in its core therapeutic...read more